Tandem Diabetes Care to Present at Three Key Investor Conferences in February-March
Event summary
- Tandem Diabetes Care will present at three investor conferences between February 26 and March 18, 2026.
- Presentations include Citi’s Unplugged MedTech and Life Sciences Access Day (Feb 26), TD Cowen Healthcare Conference (Mar 4), and Oppenheimer Healthcare MedTech & Services Conference (Mar 18).
- Webcasts will be available live and archived for 30 days on Tandem’s Investor Center.
- Company focuses on advanced automated insulin delivery systems, including the Tandem Mobi system and t:slim X2 pump with Control-IQ+ technology.
The big picture
Tandem Diabetes Care’s upcoming investor conference appearances come as the company seeks to solidify its leadership in automated insulin delivery. The presentations will be closely watched for updates on product adoption, regulatory developments, and competitive dynamics in a market increasingly focused on closed-loop diabetes management solutions.
What we're watching
- Market Positioning
- How Tandem’s messaging will position it against competitors in the automated insulin delivery space.
- Technology Adoption
- The pace at which Control-IQ+ and Tandem Mobi gain market share amid evolving diabetes management trends.
- Investor Sentiment
- Whether the presentations will shift investor perception of Tandem’s growth trajectory and valuation.
Related topics